l carnitine and glutathione A glutathione-responsive L-carnitine-modified camptothecin oral nano-prodrug for cancer therapy glutathione with l carnitine Simply
Description
, & Baeuerle, P
Unauthorized injectable drugs may pose serious health risks
Moisture can lead to peptide hydrolysis and degradation
In late 2024, the FDA issued a series of Warning Letters to entities marketing peptides online for human use, notwithstanding attempts to characterize the products as for research use only. These letters alleged violations of the Federal Food, Drug, and Cosmetic Act (FDCA), specifically the marketing and sale of misbranded and unapproved new drugs and warned of escalation to seizures or injunctions if these violations were not promptly corrected
